Replies to post #444703 on Anavex Life Sciences Corp (AVXL)

[kevindenver]

I strongly doubt the compensation package afforded to the CEO has much of any bearing on anything right now.

Missling's compensation package is quite generous and he does very much have control in many matters in his role as CEO. This is true. However to say "something does not smell right" just seems preposterous to me. You got brandy or rum in that nog? ;)

Peace to you my friend and happy new year.

[mike_dotcom]

"he's young enough to enjoy it!" Yep, I believe everybody on this board will be dead and gone before they have an approved product.

[crescentmotor]

Something does not smell right

It sure doesn't. Even considering the safety check, which Missling certainly would have been aware of when giving out the second quarter guidance for the Rett's data, the top line EXCELLENCE data for only 84 patients should have been out by September at the latest. It seems just like yesterday when we went through the same type of extended delay with the AD top line results, only to finally see data that resulted in confusion among investors and the Street with changes in the details forthcoming for months afterward. The end result of all that confusion left investors with a huge drop in AVXL's stock price. I'm praying history doesn't repeat itself with the EXCELLENCE data.